Polypodium leucotomos extract (PLE) comes from a fern, often listed under the name Phlebodium aureum. It is taken by mouth and has been studied for sun sensitivity and skin conditions.
Also known as: Phlebodium aureum, PLE, calaguala, fern extract, golden polypody.
A vitiligo trial used 250 mg three times a day for about 6 months alongside light therapy (Middelkamp-Hup 2007). These are study protocols, not a recommendation.
The NIH Dietary Supplement Label Database lists Polypodium leucotomos extract products such as one from Herbadiet as a dietary supplement. Under the 1994 dietary supplement law (DSHEA), FDA does not approve dietary supplements before they are marketed, and the maker, not FDA, is responsible for safety and labeling.
What studies show: in 21 volunteers, oral PLE raised the amount of UV light needed to cause sunburn about 2.8-fold (González 1997). This was a small lab study, not a test of everyday sun protection. In a trial in 50 people with vitiligo who also had light therapy, repigmentation of the head and neck was 44% with PLE versus 27% with placebo, a difference that was not statistically significant overall (Middelkamp-Hup 2007). In 105 children and teens with eczema, 6 months of PLE did not reduce steroid cream use but did reduce days on antihistamine pills (Ramírez-Bosca 2012). A 2025 review counted 11 randomized trials across skin conditions, most of them small (Zundell 2025).
Safety: the 2025 review described the safety record as encouraging (Zundell 2025). The sources here do not describe drug interactions.
We could not find a single published half-life or time to peak for Polypodium leucotomos extract that applies to a supplement dose, so we do not list one. Plant extracts are mixtures of many compounds, so no single figure would describe them.
How Dose Track handles peptides · Reconstitution calculator · Half-life calculator